Cargando…
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study
BACKGROUND: Tyrosine kinase inhibitors (TKIs) are the standard of care for resectable and metastatic non-small-cell lung cancer (NSCLC) harbouring epidermal growth factor receptor (EGFR) mutations (EGFRm). We describe the real-world practice of EGFRm testing, prevalence, treatment and outcomes in EG...
Autores principales: | Jazieh, Abdul Rahman, Onal, Huseyin Cem, Tan, Daniel Shao-Weng, Soo, Ross A., Prabhash, Kumar, Kumar, Amit, Huggenberger, Reto, Cho, Byoung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478745/ https://www.ncbi.nlm.nih.gov/pubmed/36119641 http://dx.doi.org/10.1177/17588359221122720 |
Ejemplares similares
-
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset
por: Prabhash, Kumar, et al.
Publicado: (2023) -
Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort
por: Van Dao, Tu, et al.
Publicado: (2022) -
Real‐world KINDLE‐Latin America subset data on treatment patterns and clinical outcomes in patients with stage III non‐small‐cell lung cancer
por: Martin, Claudio Marcelo, et al.
Publicado: (2022) -
Using Kindle: your guide to all things Kindle and Kindle DX
por: Cheshire, Jim
Publicado: (2011) -
Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience
por: Noronha, Vanita, et al.
Publicado: (2020)